[Infections and male infertility].

Infections et infertilité masculine.
Epididymitis Infections des glandes accessoires masculines Infertilité masculine Leucospermia Leucospermie Male accessory gland infections Male infertility Orchite Orchitis Prostatite Prostatitis Épididymite

Journal

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie
ISSN: 1166-7087
Titre abrégé: Prog Urol
Pays: France
ID NLM: 9307844

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 23 08 2023
revised: 08 09 2023
accepted: 12 09 2023
medline: 29 11 2023
pubmed: 28 11 2023
entrez: 28 11 2023
Statut: ppublish

Résumé

The role of urogenital infections in male infertility has long been the subject of debate. A bibliographic search limited to English-language literature on human subjects published before 5/2023 resulted in the selection of 189 articles. Male infertility is often of multifactorial aetiology, and to optimise the prognosis it is important to manage all the factors that can be corrected, including infectious causes, which represent one of the most frequent aetiologies. The infectious agents involved in urogenital infections are most often bacterial or viral, and more rarely parasitic. They can infect the seminal tract, male accessory glands and/or testicles, and usually result in inflammation and increased oxidative stress. These infections reduce male fertility, in particular by altering spermogram parameters and increasing sperm DNA fragmentation. For these reasons, the search for a urogenital infection should be systematic, involving a careful history and clinical examination, ultrasound and systematic bacteriological tests guided by clinical findings. Aetiological treatment may be proposed depending on the picture and the germ involved. This review should help the urologist to establish an accurate diagnosis of the form and extent of the infection, and enable him to define an appropriate therapeutic strategy, tailored to the patient, in order to obtain the best chances of improving male fertility.

Sections du résumé

BACKGROUND BACKGROUND
The role of urogenital infections in male infertility has long been the subject of debate.
METHODS METHODS
A bibliographic search limited to English-language literature on human subjects published before 5/2023 resulted in the selection of 189 articles.
RESULTS RESULTS
Male infertility is often of multifactorial aetiology, and to optimise the prognosis it is important to manage all the factors that can be corrected, including infectious causes, which represent one of the most frequent aetiologies. The infectious agents involved in urogenital infections are most often bacterial or viral, and more rarely parasitic. They can infect the seminal tract, male accessory glands and/or testicles, and usually result in inflammation and increased oxidative stress. These infections reduce male fertility, in particular by altering spermogram parameters and increasing sperm DNA fragmentation. For these reasons, the search for a urogenital infection should be systematic, involving a careful history and clinical examination, ultrasound and systematic bacteriological tests guided by clinical findings. Aetiological treatment may be proposed depending on the picture and the germ involved.
CONCLUSION CONCLUSIONS
This review should help the urologist to establish an accurate diagnosis of the form and extent of the infection, and enable him to define an appropriate therapeutic strategy, tailored to the patient, in order to obtain the best chances of improving male fertility.

Identifiants

pubmed: 38012909
pii: S1166-7087(23)00217-8
doi: 10.1016/j.purol.2023.09.015
pii:
doi:

Types de publication

Review English Abstract Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

636-652

Informations de copyright

Copyright © 2023 Elsevier Masson SAS. All rights reserved.

Auteurs

F Saint (F)

Service d'urologie-transplantation, CHU Amiens Picardie, Amiens, France; Laboratoire EPROAD EA 4669, université Picardie Jules-Verne, Amiens, France.

E Huyghe (E)

Département d'urologie, hôpital de Rangueil, CHU de Toulouse, Toulouse, France; Service de médecine de la reproduction, hôpital Paule-de-Viguier, CHU de Toulouse, Toulouse, France; UMR DEFE, Inserm 1203, université de Toulouse, université de Montpellier, Montpellier, France. Electronic address: eric.huyghe@yahoo.fr.

C Methorst (C)

Service de médecine de la reproduction, hôpital des 4 villes, Saint-Cloud, France.

A Priam (A)

Service d'urologie-transplantation, CHU Amiens Picardie, Amiens, France.

E Seizilles de Mazancourt (E)

Urologie, CHU Lyon sud, Pierre-Bénite, France.

F Bruyère (F)

Urologie, CHRU de Tours, Tours, France.

A Faix (A)

Clinique Saint-Roch, 560, avenue du Colonel-Pavelet-dit-Villars, 34000 Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH